Dr. Shibaji Ghosh
Academic Qualifications
Contact Details
Dr. Shibaji Ghosh
Sr. Principal Scientist
shibajighosh@csmcri.res.in
7850 / 2567760
In the field of Law & Management (As Corresponding Author)
28. Ghosh Shibaji*, Beyond Compensation: The Expanding Role of Patent Term Extensions in Pharmaceuticals. European Intellectual Property Review 48 (9), 555–557 (2026) [ABDC-A].
27. Ghosh Shibaji*, Intellectual Property Dilemmas in AI-Powered Drug Discovery: Balancing Innovation and Access. European Intellectual Property Review 48 (1), 26–33 (2026) [ABDC-A].
26. Surya M Tripathi, Ghosh Shibaji*, Patent Examination Process through AI and its Challenges in India, EU and the US. European Intellectual Property Review 47 (9), 552–560 (2025) [ABDC-A].
25. Ghosh Shibaji*, International Patent Opposition via Patent Cooperation Treaty (PCT). European Intellectual Property Review 47 (8), 470–472 (2025) [ABDC-A].
24. Ghosh Shibaji*, Patents and Circular Economy: Legal Implications for Recycling Technologies. European Intellectual Property Review 47 (6), 325–332 (2025) [ABDC-A].
23. Ghosh Shibaji*, Patent Opposition Systems - A global Overview. European Intellectual Property Review 47 (2), 102–112 (2025) [ABDC-A].
22. Verma, B., Agarwal, A., Maiti, P. & Ghosh Shibaji*, Pre-grant opposition: a strategic tool for patent invalidation and boosting innovation. International Journal of Intellectual Property Management 15, 162–179 (2025) [ABDC-C].
21. Verma, B. & Ghosh Shibaji*, Pre-Grant opposition: CSIR v MS Hindustan Lever Limited. Journal of Intellectual Property Rights 28, 544–554 (2023) [Scopous-Q3].
In the field of Science/Drug Designing (As First Author)
20. Wakchaure, P. D., Ghosh Shibaji (equal author) & Ganguly, B. Revealing the inhibition mechanism of RNA-Dependent RNA polymerase (RDRP) of SARS-COV-2 by remdesivir and nucleotide analogues: a Molecular Dynamics Simulation study. The Journal of Physical Chemistry B 124, 10641–10652 (2020) (IF-2.99) [Scopus-Q1].
19. Ghosh Shibaji, Jana, K., Wakchaure, P. D. & Ganguly, B. Revealing the cholinergic inhibition mechanism of Alzheimer’s by galantamine: a metadynamics simulation study. Journal of Biomolecular Structure and Dynamics 40, 5100–5111 (2020) (IF-3.31) [Scopus-Q2].
18. Ghosh Shibaji, Jana, K. & Ganguly, B. Revealing the mechanistic pathway of cholinergic inhibition of Alzheimer’s disease by donepezil: a metadynamics simulation study. Physical Chemistry Chemical Physics 21, 13578–13589 (2019) (IF-3.9) [Scopus-Q2].
17. Ghosh Shibaji, Jana, K. & Ganguly, B. Influence of gauche effect on uncharged oxime reactivators for the reactivation of tabun-inhibited AChE: quantum chemical and steered molecular dynamics studies. Journal of Computer-Aided Molecular Design 32, 793–807 (2018) (IF-3.02) [Scopus-Q2].
16. Ghosh Shibaji, Chandar, N. B., Jana, K. & Ganguly, B. Revealing the importance of linkers in K-series oxime reactivators for tabun-inhibited AChE using quantum chemical, docking and SMD studies. Journal of Computer-Aided Molecular Design 31, 729–742 (2017) (IF-3.02) [Scopus-Q2].
15. Ghosh Shibaji, Chandar, N. B., Lo, R. & Ganguly, B. Effective docking program for designing reactivator for treating organophosphorus inhibited AChE. JSM Chemistry 04, 1032 (2016).
In the field of Science/Drug Designing (As Co-Author)
14. Dipankar Das, Shibaji Ghosh, Kalyanashis Jana, Bishwajit Ganguly. Unraveling the stereoisomeric toxicity of V-series nerve agent VX on human acetylcholinesterase: a well-tempered metadynamics study. Physical Chemistry Chemical Physics, 2026,28, 1281-1292 (IF-3.6) [Scopus-Q2].
13. Shome, A., Ali, S., Roy, D., Dey, S., Sinha, S., Barman, P., Kumar, A., Chakroborty, R., Haydar, M. S., Roy, S., Ghosh, S. & Roy, M. N. Phyto-assisted eco-benevolent synthesis of oxidase-mimic Cu–Mn3O4 as an antibacterial and antiproliferative agent. Bioprocess and Biosystems Engineering (2025). doi:10.1007/s00449-025-03149-x, (IF-3.6) [Scopus-Q2].
12. Das, T. K., Ghosh, P., Dhembare, H. M., Mandal, A., Ghosh, S. & Das, S. Site Selective C(sp2 )2-H Sulfenylation of 4-Quinolone Derivatives under Palladium(II) Catalysis. Chem Asian J., e00535 (2025). doi:10.1002/asia.202500535, (IF-3.3).
11. Das, T. K., Ghosh, P., Ghosh, S. & Das, S. Palladium-Catalyzed, Site-Selective C(sp2)8–H Halogenation and Nitration of 4-Quinolone Derivatives. The Journal of Organic Chemistry 89, 11467–11479 (2024), (IF-3.6) [Scopus-Q2].
10. Ali, S., Sikdar, S., Basak, S., Mondal, M., Tudu, A., Roy, D., Haydar, M. S., Ghosh, S., Rahaman, H., Sil, S. & Roy, M. N. Multienzyme Mimicking Cascade Mn3O4 Catalyst to Augment Reactive Oxygen Species Elimination and Colorimetric Detection: A Study of Phase Variation upon Calcination Temperature. Inorganic Chemistry 63, 10542–10556 (2024) (IF-4.7) [Scopus-Q1].
9. Ghosh, R., Nair, R. R., Ghosh, S., Debnath, S. & Chatterjee, P. B. A Water-Soluble wavy coordination polymer of CU(II) as a Turn-On luminescent probe for histidine and Histidine-Rich Proteins/Peptides. Inorganic Chemistry 63, 8320–8328 (2024) (IF-4.7) [Scopus-Q1].
8. Hajra, A. K., Ghosh, P., Roy, C., Kundu, M., Ghosh, S. & Das, S. Copper(II)-catalyzed, Site Selective C(sp2)–H Amination using 8-Aminoimidazo[1,2-a]pyridine (AIP) as Directing group. Organic & Biomolecular Chemistry 22, 6617–6630 (2024) (IF-2.7).
7. Ali, S., Sikdar, S., Basak, S., Haydar, M. S., Mallick, K., Mondal, M., Roy, D., Ghosh, S., Sahu, S., Paul, P. & Roy, M. N. Label-Free detection of epinephrine using flower-like biomimetic CUS antioxidant nanozymes. Inorganic Chemistry 62, 11291–11303 (2023) (IF-4.7) [Scopus-Q1].
6. Ali, S., Sikdar, S., Basak, S., Mondal, M., Mallick, K., Haydar, M. S., Ghosh, S. & Roy, M. N. Assemble multi-enzyme mimic tandem Mn3O4@ g-C3N4 for augment ROS elimination and label free detection. Chemical Engineering Journal 463, 142355 (2023) (IF-16.67) [Scopus-Q1].
5. Roy, S., Ghosh, P., Ghosh, S., Mondal, S. K., Mandal, A. & Das, S. Regioselective C(sp2)3−H thiocyanation of substituted 4H‐pyrido[1,2‐a]pyrimidin‐4‐ones and its derivatizations. ChemistrySelect 8, (2023) (IF-2.0) [Scopus-Q3].
4. Jana, K., Wakchaure, P. D., Ghosh, S., Bandyopadhyay, T. & Ganguly, B. Quantum chemical and well-tempered metadynamics study to design adenine analogs for orthogonal Preq1 riboswitch. Journal of Biomolecular Structure and Dynamics 38, 4635–4643 (2019) (IF-3.31) [Scopus-Q2].
3. Jana, K., Ghosh, S., Wakchaure, P. D., Bandyopadhyay, T. & Ganguly, B. Probing the role of imidazopyridine and imidazophosphorine scaffolds to design novel proton pump inhibitor for H+,K+-ATPASe: a DFT study. ACS Omega 4, 1311–1321 (2019) (IF-2.58) [Scopus-Q1].
2. Lo, R., Chandar, N. B., Ghosh, S. & Ganguly, B. The reactivation of tabun-inhibited mutant AChE with Ortho-7: steered molecular dynamics and quantum chemical studies. Molecular BioSystems 12, 1224–1231 (2016) (IF-3.21).
1. Chandar, N. B., Ghosh, S., Lo, R., Banjo, S. & Ganguly, B. In silico studies on the role of mutant Y337A to reactivate tabun inhibited mAChE with K048. Chemico-Biological Interactions 242, 299–306 (2015) (IF-2.58) [Scopus-Q1].
1. Shibaji Ghosh, Mrinal Kanti Si, Vijay Anand Gopalakrishnan, Pradipkumar Vaghela, Ramavatar Meena, Arup Ghosh, Bio-stimulant formulation from Kappaphycus Alvarezii and Caulerpa, PCT Publication No WO2024194894.
2. Shibaji Ghosh, Mrinal Kanti Si, Vijay Anand Gopalakrishnan, Pradipkumar Vaghela, Ramavatar Meena, Arup Ghosh, Bio-stimulant formulation from Kappaphycus alvarezii and Caulerpa sp, Indian Patent Application No IN202311020223, Philippines Application No- 1-2025-552234, and Indonesia Application No- 1P00202509208.
3. Bishwajit Ganguly, Mrinal Kanti Si, Sumit Kumar Pramanik and Shibaji Ghosh; A G-Quadruplex-DNA binder and its method of preparation thereof; Indian Granted Patent No IN423723.
4. Dhruvatiba Rajendrasinh Gohil Arvind Kumar, Sumesh Chandra Upadhyay, Jifu Zhao, Alok Ranjan Paital, Sumit Balkrishna Kamble, Parul Sahu, Rahul Jasvantrai Sanghavi, Shibaji Ghosh, Jasbir Kaur Mahey, Dipak Uka Nandaniya, An integrated process for preparation of pure brine for industrial use by recovery of marine salts and bromine, Indian Patent Application No IN202411018403.
Intellectual property law and management, pharmaceutical patents, patent term extensions, data exclusivity, AI-enabled drug discovery, technology transfer, innovation policy, IP strategy, patent analytics, licensing and commercialization, research governance, computational drug discovery, and interdisciplinary research at the interface of law, science, and public policy.
